Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Newcastle, UK)"'
Autor:
Pruis MA; Department of Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Krebs MG; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Plummer R; Oncology Department, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle, UK., De Vos F; Department Medical Oncology, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands., Angevin E; Drug Development Department (DITEP), Gustave Roussy Institute, Villejuif, France., Prenen H; Department of Medical Oncology, University Hospital Antwerp, Antwerp, Belgium., Forster MD; Department of Oncology, UCL Cancer Institute/ University College London Hospitals NHS Foundation Trust, London, UK., Clack G; Octimet Oncology NV, Belgium., Van der Aa A; Octimet Oncology NV, Belgium., Tjwa M; Octimet Oncology NV, Belgium., Jansen E; Octimet Oncology NV, Belgium., Perera T; Department of Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Octimet Oncology NV, Belgium., Lolkema MP; Department of Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
The oncologist [Oncologist] 2023 Dec 11; Vol. 28 (12), pp. e1248-e1258.
Autor:
Ferguson J; Glasgow Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Tsim S; Glasgow Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Kelly C; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK., Alexander L; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK., Shad S; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK., Neilly M; Glasgow Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Tate M; Glasgow Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Zahra B; Glasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, UK., Saleh M; Glasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, UK., Cowell G; Department of Radiology, Queen Elizabeth University Hospital, Glasgow, UK., Banks E; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK., Grundy S; Department of Respiratory Medicine, Salford Royal Hospital, Salford, UK., Corcoran J; Interventional Pulmonology Service, Department of Respiratory Medicine, Plymouth Hospitals NHS Trust, Plymouth, UK., Downer N; Department of Respiratory Medicine, King's Mill Hospital, Sutton-in-Ashfield, UK., Stanton A; Department of Respiratory Medicine, Freeman Hospital, Newcastle, UK., Evison M; Department of Respiratory Medicine, University Hospital of South Manchester, Manchester, UK., Rahman NM; Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, UK., Maskell N; Bristol Medical School, University of Bristol Academic Respiratory Unit, Bristol, UK., Blyth KG; Glasgow Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK kevin.blyth@glasgow.ac.uk.; School of Cancer Sciences, University of Glasgow, Glasgow, UK.
Publikováno v:
BMJ open respiratory research [BMJ Open Respir Res] 2023 Nov 23; Vol. 10 (1). Date of Electronic Publication: 2023 Nov 23.
Autor:
Christofyllakis K; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, Saarland University Medical Center, Homburg, Germany. Electronic address: Konstantinos.christofyllakis@uks.eu., Monteiro AR; Medical Oncology Department, Vila Nova de Gaia/Espinho Hospital Center, Vila Nova de Gaia, Portugal; Multidisciplinary Thoracic Tumors Unit - Pulmonology Department, Vila Nova de Gaia/Espinho Hospital Center, Vila Nova de Gaia, Portugal., Cetin O; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, Saarland University Medical Center, Homburg, Germany., Kos IA; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, Saarland University Medical Center, Homburg, Germany., Greystoke A; Northern Centre for Cancer Care, Newcastle-upon-Tyne NHS Foundation trust, Newcastle, UK., Luciani A; Department of Medical Oncology, Ospedale di Treviglio- ASST Bergamo Ovest, Treviglio, Italy.
Publikováno v:
Journal of geriatric oncology [J Geriatr Oncol] 2022 Nov; Vol. 13 (8), pp. 1071-1083. Date of Electronic Publication: 2022 May 05.
Autor:
Moreno V; START Madrid-FJD, Hospital Fundación Jiménez Díaz, Madrid, Spain., Roda D; University Hospital INCLIVA, Valencia, Spain., Pikiel J; Szpitale Pomorskie, Szpital Morski, Gdynia, Poland., Trigo J; Hospital Universitario Virgen de la Victoria, IBIMA, Málaga, Spain., Bosch-Barrera J; Catalan Institute of Oncology (ICO), Hospital Universitari Dr Josep Trueta, Girona, Spain., Drew Y; Clinical and Translational Institute, Newcastle University, Newcastle, UK., Kristeleit R; University College London Cancer Institute, UCL, London, UK., Hiret S; Institut de Cancérologie de l'Ouest, René Gauducheau, St Herblain, France., Bajor DL; University Hospitals Cleveland Medical Centre, Cleveland, OH., Cruz P; La Paz University Hospital, Madrid, Spain., Beck JT; Highlands Oncology Group, Springdale, AR., Ghosh S; GSK, Collegeville, PA., Dabrowski C; GSK, Collegeville, PA., Antony G; GSK, Brentford, UK., Duan T; GSK, Waltham, MA., Veneris J; GSK, Waltham, MA., Zografos E; GSK, Stevenage, Hertfordshire, UK., Subramanian J; Saint Luke's Cancer Institute, Kansas City, MO. Electronic address: janakiraman.subramanian@inova.org.
Publikováno v:
Clinical lung cancer [Clin Lung Cancer] 2022 Nov; Vol. 23 (7), pp. e415-e427. Date of Electronic Publication: 2022 May 23.
Autor:
Felip E; Thoracic Cancer Unit, Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Moreno V; Phase 1 Trials Unit, START MADRID-FJD, Hospital Fundación Jiménez Díaz Medical Oncology Division, Madrid, Spain., Morgensztern D; Division of Oncology, Section of Medical Oncology, Washington University School of Medicine, St. Louis, MO, USA., Curigliano G; Division of Early Drug Development, European Institute of Oncology, IRCCS and University of Milano, Milan, Italy., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Trigo JM; Department of Medical Oncology, Hospital Universitario Virgen de La Victoria y Regional, Malaga, Spain., Calvo A; Oncology Service, Hospital General Universitario Gregorio Maranon, Madrid, Spain., Kowalski D; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Cortinovis D; Oncology Unit, San Gerardo Hospital, Monza, Italy., Plummer R; Sir Bobby Robson Unit, Northern Centre for Cancer Care, Newcastle Hospitals NHS Trust and Newcastle University, Newcastle, UK., Maio M; Center for Immuno-Oncology, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy., Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS-Fondazione Pascale, Napoli, Italy., Vladimirov VI; Pyatigorsky Oncology Dispensary, Pyatigorsk, Russia., Cervantes A; Medical Oncology Department, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain., Zudaire E; Janssen Research & Development, Spring House, PA, USA., Hazra A; Janssen Research & Development, Spring House, PA, USA., T'jollyn H; Janssen Research & Development, Beerse, Belgium., Bandyopadhyay N; Janssen Research & Development, Raritan, NJ, USA., Greger JG; Janssen Research & Development, Spring House, PA, USA., Attiyeh E; Janssen Research & Development, Spring House, PA, USA., Xie H; Janssen Research & Development, Spring House, PA, USA., Calvo E; Centro Integral Oncológico Clara Campal Medical Oncology Division, START Madrid-CIOCC, Sanchinarro University Hospital, Madrid, Spain. emiliano.calvo@startmadrid.com.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2022 Apr; Vol. 89 (4), pp. 499-514. Date of Electronic Publication: 2022 Mar 17.
Autor:
Lindsay CR; Division of Molecular and Clinical Cancer Sciences, University of Manchester, Manchester, UK. colin.lindsay@manchester.ac.uk.; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. colin.lindsay@manchester.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, London and Manchester, Manchester, UK. colin.lindsay@manchester.ac.uk., Shaw EC; Department of Histopathology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, London and Manchester, Manchester, UK.; Department of Cellular Pathology, University College London Hospital NHS Foundation Trust, London, UK., Rassl D; Department of Histopathology, Papworth Hospital, Cambridge, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, London and Manchester, Manchester, UK.; Department of Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK., Steele N; Department of Medical Oncology, the Beatson West of Scotland Cancer Centre, Glasgow, UK., Naheed S; Department of Medical Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Dick C; Department of Pathology, Queen Elizabeth University Hospital, Glasgow, UK., Taylor F; Department of Medical Oncology, Weston Park Cancer Centre, Sheffield, UK., Adderley H; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Black F; Department of Histopathology, the Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK., Summers Y; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Evans M; Department of Histopathology, Black Country Pathology Services, Royal Wolverhampton NHS Trust, Wolverhampton, UK., Rice A; Department of Histopathology, Royal Brompton and Harefield NHS Foundation Trust, London, UK., Fabre A; Department of Histopathology, St Vincent's Healthcare Group, Dublin, Ireland., Wallace WA; Department of Pathology, Royal Infirmary of Edinburgh, Edinburgh, UK.; Division of Pathology, the University of Edinburgh, Edinburgh, UK., Nicholson S; Department of Histopathology, St James's Hospital, Dublin, Ireland., Haragan A; Department of Cellular Pathology, Royal Liverpool University Hospital, Liverpool, UK., Taniere P; Department of Histopathology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Nicholson AG; Department of Histopathology, Royal Brompton and Harefield NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College, London, UK., Laing G; Department of Pathology, Aberdeen University School of Medicine and Aberdeen Royal Infirmary, Aberdeen, UK., Cave J; Department of Medical Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Forster MD; Cancer Research UK Lung Cancer Centre of Excellence, London and Manchester, Manchester, UK.; Department of Oncology, University College of London Hospital and UCL Cancer Institute, London, UK., Blackhall F; Division of Molecular and Clinical Cancer Sciences, University of Manchester, Manchester, UK.; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, London and Manchester, Manchester, UK., Gosney J; Department of Cellular Pathology, Royal Liverpool University Hospital, Liverpool, UK., Popat S; Lung Unit, The Royal Marsden Hospital, London, UK.; Section of Clinical Studies, The Institute of Cancer Research, London, UK., Kerr KM; Department of Pathology, Aberdeen University School of Medicine and Aberdeen Royal Infirmary, Aberdeen, UK.
Publikováno v:
British journal of cancer [Br J Cancer] 2021 Oct; Vol. 125 (9), pp. 1210-1216. Date of Electronic Publication: 2021 Sep 06.
Autor:
Ratnayake CBB; Department of Surgery, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand., Wells CI; Department of Surgery, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand., Atherton P; Department of Hepatobiliary, Pancreatic and Transplant Surgery, Freeman Hospital, Newcastle upon Tyne, UK.; Department of Surgery, Freeman Hospital, Newcastle upon Tyne, UK., Hammond JS; Department of Hepatobiliary, Pancreatic and Transplant Surgery, Freeman Hospital, Newcastle upon Tyne, UK.; Department of Surgery, Freeman Hospital, Newcastle upon Tyne, UK., White S; Department of Hepatobiliary, Pancreatic and Transplant Surgery, Freeman Hospital, Newcastle upon Tyne, UK.; Department of Surgery, Freeman Hospital, Newcastle upon Tyne, UK., French JJ; Department of Hepatobiliary, Pancreatic and Transplant Surgery, Freeman Hospital, Newcastle upon Tyne, UK.; Department of Surgery, Freeman Hospital, Newcastle upon Tyne, UK., Manas D; Department of Hepatobiliary, Pancreatic and Transplant Surgery, Freeman Hospital, Newcastle upon Tyne, UK.; Department of Surgery, Freeman Hospital, Newcastle upon Tyne, UK., Pandanaboyana S; Department of Hepatobiliary, Pancreatic and Transplant Surgery, Freeman Hospital, Newcastle upon Tyne, UK.; Department of Surgery, Freeman Hospital, Newcastle upon Tyne, UK.; Population Health Sciences Institute, Newcastle University, Newcastle, UK.
Publikováno v:
ANZ journal of surgery [ANZ J Surg] 2021 Mar; Vol. 91 (3), pp. 255-263. Date of Electronic Publication: 2020 Oct 22.
Autor:
Gomes F; Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. fabio.gomes@christie.nhs.uk., Wong M; Division of Hematology/Oncology, University of California, San Francisco, CA, USA., Battisti NML; Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK., Kordbacheh T; Division of Cancer Sciences, University of Manchester, Manchester, UK., Kiderlen M; Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Greystoke A; Medical Oncology, Newcastle-upon-Tyne NHS Foundation trust, Newcastle, UK., Luciani A; Medical Oncology, Ospedale S. Paolo University Hospital, Milan, Italy.
Publikováno v:
British journal of cancer [Br J Cancer] 2020 Sep; Vol. 123 (6), pp. 874-884. Date of Electronic Publication: 2020 Jul 22.
Autor:
Middleton G; Institute of Immunology & Immunotherapy, University of Birmingham, Birmingham, UK. g.middleton@bham.ac.uk.; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. g.middleton@bham.ac.uk., Fletcher P; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Popat S; The Royal Marsden Hospital, London, UK., Savage J; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Summers Y; The Christie, Manchester, UK., Greystoke A; Newcastle University, Newcastle, UK., Gilligan D; Addenbrooke's Hospital, Cambridge, UK., Cave J; Southampton University Hospitals NHS Trust, Southampton, UK., O'Rourke N; Beatson West of Scotland Cancer Centre, Glasgow, UK., Brewster A; Velindre Cancer Centre, Cardiff, UK., Toy E; Royal Devon and Exeter Foundation NHS Trust, Exeter, UK., Spicer J; King's College London, Guy's Hospital, London, UK., Jain P; St James's University Hospital, Leeds, UK., Dangoor A; Bristol Haematology and Oncology Centre, Bristol, UK., Mackean M; Western General Hospital, Edinburgh, UK., Forster M; University College Hospital, London, UK., Farley A; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Wherton D; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Mehmi M; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Sharpe R; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Mills TC; Cancer Research UK, London, UK., Cerone MA; Cancer Research UK, London, UK., Yap TA; The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Watkins TBK; The Francis Crick Institute, London, UK., Lim E; The Francis Crick Institute, London, UK., Swanton C; The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK., Billingham L; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
Publikováno v:
Nature [Nature] 2020 Jul; Vol. 583 (7818), pp. 807-812. Date of Electronic Publication: 2020 Jul 15.
Autor:
Sanganalmath P; Weston Park Hospital, Sheffield, UK., Lester JE; Weston Park Hospital, Sheffield, UK., Bradshaw AG; Weston Park Hospital, Sheffield, UK; Newcastle on Tyne Hospitals NHS Trust, Freeman Hospital, Newcastle, UK., Das T; Weston Park Hospital, Sheffield, UK., Esler C; University Hospitals of Leicester NHS Trust, Leicester, UK., Roy AEF; Plymouth Hospitals NHS Trust, Plymouth, UK., Toy E; Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Lester JF; Velindre Cancer Centre, Cardiff, UK., Button M; Velindre Cancer Centre, Cardiff, UK., Wilson P; University Hospitals Bristol NHS Trust, Bristol, UK., Comins C; University Hospitals Bristol NHS Trust, Bristol, UK., Atherton P; Newcastle on Tyne Hospitals NHS Trust, Freeman Hospital, Newcastle, UK., Pickles R; Newcastle on Tyne Hospitals NHS Trust, Freeman Hospital, Newcastle, UK., Foweraker K; Nottingham University Hospitals NHS Trust, City Hospital, Nottingham, UK., Walker GA; Derby Hospitals NHS Trust, Royal Derby Hospital, UK., Keni M; Derby Hospitals NHS Trust, Royal Derby Hospital, UK., Hatton MQ; Weston Park Hospital, Sheffield, UK. Electronic address: matthew.hatton@sth.nhs.uk.
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2018 Mar; Vol. 30 (3), pp. 144-150. Date of Electronic Publication: 2018 Jan 12.